Home › Companies › REGENXBIO INC. › 2023-2024
Compiled from SEC Form N-PX filings and REGENXBIO INC.’s Form 8-K, filed 2024-06-03 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore REGENXBIO INC. in the interactive database Compare manager voting policies
These tallies are REGENXBIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-03 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: George Migausky | 39,124,767 | -- | -- | 1,785,552 | 3,342,209 | Majority: yes |
| Elect Director: Kenneth T. Mills | 39,258,562 | -- | -- | 1,651,757 | 3,342,209 | Majority: yes |
| Elect Director: David C. Stump | 35,039,630 | -- | -- | 5,870,689 | 3,342,209 | Majority: yes |
| Proposal 2: By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024: | 44,152,900 | 58,293 | 41,335 | -- | 0 | Majority: yes |
| Proposal 3: By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement: | 40,147,111 | 727,846 | 35,362 | -- | 3,342,209 | Majority: yes |
Source: REGENXBIO INC., Form 8-K, filed with the SEC on 2024-06-03 — read the filing on EDGAR.
Each item below shows how the 211 asset managers that disclosed a REGENXBIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of REGENXBIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
REGENXBIO INC.’s own tally for this item (“Proposal 3: By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement:”): 40,147,111 for, 727,846 against, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,043,000 outstanding shares: 82% for, 1% against (83% of the company cast a for/against vote).
The 210 asset managers below cast 99.0% of the shares they voted on this item FOR (39,108,475 for, 377,888 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 6,957,648 | 1,024 | 0 | 0 | For |
| State Street | 5,199,236 | 0 | 0 | 0 | For |
| JPMorgan | 4,909,051 | 0 | 0 | 0 | For |
| Vanguard | 4,879,100 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 4,551,556 | 0 | 0 | 0 | For |
| Avidity Partners Management LP | 1,246,556 | 0 | 0 | 0 | For |
| Dimensional | 1,138,184 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 950,551 | 0 | 0 | 0 | For |
| Fidelity | 913,658 | 0 | 0 | 0 | For |
| Charles Schwab | 666,146 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 549,078 | 0 | 0 | 0 | For |
| Northern Trust | 401,704 | 855 | 0 | 0 | For |
| WS MANAGEMENT LLLP | 351,918 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 342,418 | 0 | 0 | 0 | For |
| Aquilo Capital Management, LLC | 308,973 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 286,142 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 262,020 | 0 | 0 | 0 | For |
| ArchPoint Investors | 221,197 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 216,211 | 0 | 0 | 0 | For |
| Kintegral Advisory, LLC | 201,981 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 190,306 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 177,576 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 165,073 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 149,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 210 asset managers. See all 210 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
REGENXBIO INC.’s own tally for this item (“Proposal 2: By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024:”): 44,152,900 for, 58,293 against, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,043,000 outstanding shares: 90% for, 0.2% against (90% of the company cast a for/against vote).
The 69 asset managers below cast 99.9% of the shares they voted on this item FOR (17,777,404 for, 3,131 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,145,306 | 0 | 0 | 0 | For |
| Vanguard | 4,787,421 | 0 | 0 | 0 | For |
| State Street | 2,193,121 | 3,131 | 0 | 0 | For |
| JPMorgan | 1,503,669 | 0 | 0 | 0 | For |
| Dimensional | 962,879 | 0 | 0 | 0 | For |
| Fidelity | 912,252 | 0 | 0 | 0 | For |
| Charles Schwab | 322,699 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 262,020 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 190,306 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 116,027 | 0 | 0 | 0 | For |
| TIAA | 104,839 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 104,095 | 0 | 0 | 0 | For |
| Jackson National | 102,923 | 0 | 0 | 0 | For |
| Global X | 91,620 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 74,435 | 0 | 0 | 0 | For |
| American Century | 63,823 | 0 | 0 | 0 | For |
| BNY Mellon | 59,339 | 0 | 0 | 0 | For |
| Principal | 46,398 | 0 | 0 | 0 | For |
| Prudential/PGIM | 42,218 | 0 | 0 | 0 | For |
| ProShares | 40,884 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,271 | 0 | 0 | 0 | For |
| Thrivent | 35,111 | 0 | 0 | 0 | For |
| Northern Trust | 34,428 | 0 | 0 | 0 | For |
| Brighthouse | 13,066 | 0 | 18,237 | 0 | Abstain |
Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.
Combines 3 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
REGENXBIO INC.’s own tally for this item (“Elect Director: David C. Stump”): 35,039,630 for, 5,870,689 withheld, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,043,000 outstanding shares: 71% for, 12% withheld (83% of the company cast a for/withheld vote).
The 67 asset managers below cast 100% of the shares they voted on this item FOR (15,583,385 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,145,306 | 0 | 0 | 0 | For |
| Vanguard | 4,787,421 | 0 | 0 | 0 | For |
| State Street | 2,165,730 | 0 | 30,522 | 0 | For |
| JPMorgan | 1,503,669 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 962,879 | 0 | Abstain |
| Fidelity | 912,152 | 0 | 100 | 0 | For |
| Charles Schwab | 322,699 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 262,020 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 190,306 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 149,000 | 0 | Abstain |
| Equitable | 63,127 | 0 | 52,900 | 0 | For |
| TIAA | 0 | 0 | 104,839 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 104,095 | 0 | Abstain |
| Jackson National | 0 | 0 | 102,923 | 0 | Abstain |
| Global X | 91,620 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 74,435 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 63,823 | 0 | Abstain |
| BNY Mellon | 0 | 0 | 59,339 | 0 | Abstain |
| Principal | 125 | 0 | 46,273 | 0 | Abstain |
| Prudential/PGIM | 42,218 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 40,884 | 0 | Abstain |
| Lincoln Financial | 34,200 | 0 | 5,071 | 0 | For |
| Thrivent | 0 | 0 | 35,111 | 0 | Abstain |
| Northern Trust | 0 | 0 | 34,428 | 0 | Abstain |
| Brighthouse | 0 | 0 | 31,303 | 0 | Abstain |
Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
REGENXBIO INC.’s own tally for this item (“Elect Director: George Migausky”): 39,124,767 for, 1,785,552 withheld, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,043,000 outstanding shares: 80% for, 4% withheld (83% of the company cast a for/withheld vote).
The 67 asset managers below cast 100% of the shares they voted on this item FOR (16,714,664 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,145,306 | 0 | 0 | 0 | For |
| Vanguard | 4,787,421 | 0 | 0 | 0 | For |
| State Street | 2,193,365 | 0 | 2,887 | 0 | For |
| JPMorgan | 1,503,669 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 962,879 | 0 | Abstain |
| Fidelity | 912,252 | 0 | 0 | 0 | For |
| Charles Schwab | 322,699 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 262,020 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 190,306 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 63,127 | 0 | 52,900 | 0 | For |
| TIAA | 104,839 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 104,095 | 0 | 0 | 0 | For |
| Jackson National | 89,251 | 0 | 13,672 | 0 | For |
| Global X | 91,620 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 74,435 | 0 | 0 | 0 | For |
| American Century | 63,823 | 0 | 0 | 0 | For |
| BNY Mellon | 59,339 | 0 | 0 | 0 | For |
| Principal | 46,398 | 0 | 0 | 0 | For |
| Prudential/PGIM | 42,218 | 0 | 0 | 0 | For |
| ProShares | 40,884 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,200 | 0 | 5,071 | 0 | For |
| Thrivent | 35,111 | 0 | 0 | 0 | For |
| Northern Trust | 34,428 | 0 | 0 | 0 | For |
| Brighthouse | 13,066 | 0 | 18,237 | 0 | Abstain |
Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
REGENXBIO INC.’s own tally for this item (“Elect Director: Kenneth T. Mills”): 39,258,562 for, 1,651,757 withheld, per its Form 8-K filed 2024-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 49,043,000 outstanding shares: 80% for, 3% withheld (83% of the company cast a for/withheld vote).
The 67 asset managers below cast 100% of the shares they voted on this item FOR (16,767,564 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 5,145,306 | 0 | 0 | 0 | For |
| Vanguard | 4,787,421 | 0 | 0 | 0 | For |
| State Street | 2,193,365 | 0 | 2,887 | 0 | For |
| JPMorgan | 1,503,669 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 962,879 | 0 | Abstain |
| Fidelity | 912,252 | 0 | 0 | 0 | For |
| Charles Schwab | 322,699 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 262,020 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 190,306 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 116,027 | 0 | 0 | 0 | For |
| TIAA | 104,839 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 104,095 | 0 | 0 | 0 | For |
| Jackson National | 89,251 | 0 | 13,672 | 0 | For |
| Global X | 91,620 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 74,435 | 0 | 0 | 0 | For |
| American Century | 63,823 | 0 | 0 | 0 | For |
| BNY Mellon | 59,339 | 0 | 0 | 0 | For |
| Principal | 46,398 | 0 | 0 | 0 | For |
| Prudential/PGIM | 42,218 | 0 | 0 | 0 | For |
| ProShares | 40,884 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,200 | 0 | 5,071 | 0 | For |
| Thrivent | 35,111 | 0 | 0 | 0 | For |
| Northern Trust | 34,428 | 0 | 0 | 0 | For |
| Brighthouse | 13,066 | 0 | 18,237 | 0 | Abstain |
Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,593 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SYNTAX ETF TRUST | 1,543 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 50 | 0 | 0 | 0 | For |
Ranked by the number of REGENXBIO INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 49,043,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 14.19% |
| 2 | State Street | 10.60% |
| 3 | JPMorgan | 10.01% |
| 4 | Vanguard | 9.95% |
| 5 | Redmile Group, LLC | 9.28% |
| 6 | Avidity Partners Management LP | 2.54% |
| 7 | Dimensional | 2.32% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.94% |
| 9 | Fidelity | 1.86% |
| 10 | Charles Schwab | 1.36% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 12.99% | 13F |
| Redmile Group, LLC | 10.10% | DEF14A |
| JPMorgan Chase | 8.23% | 13F |
| Vanguard Group | 6.81% | 13F |
| State Street | 6.37% | 13F |
| Entities Affiliated with Allan M. Fox Bryn Mawr Trust Company | 5.88% | DEF14A |
| Goldman Sachs | 3.78% | 13F |
| Morgan Stanley | 3.48% | 13F |
| Dimensional Fund Advisors | 2.44% | 13F |
| Geode Capital | 1.94% | 13F |
Percentages above are of 49,043,000 shares outstanding, as reported by REGENXBIO INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REGENXBIO INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At REGENXBIO INC.'s shareholder meeting held 2024-05-31, in the 2023-2024 proxy season, 211 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,358 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: REGENXBIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-03.
REGENXBIO INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.